FDA expected to okay ‘mix and match’ strategy for boosters

October 19, 2021 by Chain Drug Review booster shot of COVID-19 vaccine, FDA, two-dose Moderna and single-shot Johnson & Johnson vaccines Leading Headlines, Pharmacy

WASHINGTON — According to published reports, the Food and Drug Administration will soon allow Americans to receive a booster shot of COVID-19 vaccine different from their original dose. The federal drug regulator is expected to announce the so-called “mix and match” strategy on Wednesday when it officially authorizes boosters of the two-dose Moderna and single-shot